Moneycontrol PRO
Upcoming Event:Attend Algo Convention Live, 2 Days & 12+ Speakers at best offer Rs.999/-, exclusive for Moneycontrol Pro subscribers. Register now!

1.28 crore people covered under corona insurance policies: IRDAI chief Subhash Chandra Khuntia

During the pandemic, two corona-specific products -- Corona Kavach and Corona Rakshak -- were launched by insurers under the guidance of the Insurance Regulatory and Development Authority of India (Irdai). Besides, the insurers also introduced coverage against COVID-19.

January 29, 2021 / 03:57 PM IST

As many as 1.28 crore lives have been covered under corona-specific insurance products in the country so far with a premium collection of over Rs 1,000 crore, IRDAI Chairman Subhash Chandra Khuntia said on Friday.

During the pandemic, two corona-specific products -- Corona Kavach and Corona Rakshak -- were launched by insurers under the guidance of the Insurance Regulatory and Development Authority of India (IRDAI). Besides, the insurers also introduced coverage against COVID-19.

"Under Corona Kavach, which is the standard product (introduced during the pandemic), 42 lakh lives have been protected; while 5.36 lakh lives have been protected through Corona Rakshak.

"And, from all kinds of corona-specific products, a total of 1.28 crore lives have been covered with a total premium of more than Rs 1,000 crore," Khuntia said.

He was addressing a virtual conference during the annual summit of the Insurance Brokers Association of India (IBAI).


COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more

Addressing the insurance brokers under the fold of IBAI, the IRDAI chief said there is a huge opportunity for the brokers and insurers in the country after the pandemic and it has made people realise the need to get insured.

Khuntia said there should be more focus on tier-II, -III and -IV cities now as the growth will come from these areas.

"I have suggested them (brokers) that they should look at tier-II, -III, -IV towns and possibly the rural areas, because the higher economic growth will come from those areas now.

"We are happy now that with constant efforts by the government to control the pandemic, things are now appearing better," he said.

Hopeful for an economic revival with the falling cases of coronavirus in the country and that people are getting vaccinated, he said huge opportunities lie in terms of insuring the small business units, properties and dwelling units, among others.

Follow our LIVE blog for latest updates of the novel coronavirus pandemic

Also, presenting statistics related to reach of the insurance brokers in soliciting policies, he said the focus more is on the non-life segment by them and it has to be enhanced in life segment also.

The number of active brokers right now is 482 in the country and their contribution to general insurance business is 26 percent. It has gone up from 22 percent in 2017-18 to 26 percent now.

In health insurance their contribution is 23 percent. They have better contribution in the group health insurance business at 36 percent; and in individual health business, it is only 4.3 percent.

"So, there is opportunity for improvement. In case of life insurance their contribution is only 1.1 percent, so they are mostly concentrated in the non life sector," he added.

The IRDAI chairman also urged the brokers to focus on small business units that present huge growth opportunity.

IBAI President Sumit Bohra said, "In the past decade, the Indian non-life insurance industry has really come into its own with over Rs 1.89 lakh crore placed in premium during 2019-20, registering a growth of 10.58 percent on a year-on-year basis."

He added that for the industry to further thrive and get to the next level of growth, it is imperative that insurance penetration grows to a level comparable to the more developed insurance markets.

Follow our full coverage of the coronavirus pandemic here.

Download your money calendar for 2022-23 here and keep your dates with your moneybox, investments, taxes

first published: Jan 29, 2021 03:55 pm
ISO 27001 - BSI Assurance Mark